全部所有文章
-
聯生藥治療愛滋病單株抗體UB-421之雞尾酒取代性療法 獲准展開第三期臨床試驗
聯生藥治療愛滋病單株抗體UB-421之雞尾酒取代性療法 獲准展開第三期臨床試驗聯生藥治療愛滋病單株抗體UB-421之雞尾酒取代性療法 獲准展開第三期臨床試驗more -
United BioPharma UB-921 granted approval from TFDA for Phase I clinical trial of breast cancer treatment
United BioPharma UB-921 granted approval from TFDA for Phase I clinical trial of breast cancer treatmentUnited BioPharma UB-921 granted approval from TFDA for Phase I clinical trial of breast cancer treatmentmore -
Former Area Head of North Asia Clinical Management of PPD to join United BioPharma
Former Area Head of North Asia Clinical Management of PPD to join United BioPharmaFormer Area Head of North Asia Clinical Management of PPD to join United BioPharmamore -
United BioPharma Closes A Fundraising of NT$ 900 Million
United BioPharma Closes A Fundraising of NT$ 900 MillionUnited BioPharma Closes A Fundraising of NT$ 900 Millionmore -
United BioPharma had received the “2017 Potential Benchmark Award"
United BioPharma had received the “2017 Potential Benchmark Award"United BioPharma had received the “2017 Potential Benchmark Award"more -
United BioPharma Filed IND to Taiwan, China and Thailand FDA for UB-421 Phase III HAART Substitution Study
United BioPharma Filed IND to Taiwan, China and Thailand FDA for UB-421 Phase III HAART Substitution StudyUnited BioPharma Filed IND to Taiwan, China and Thailand FDA for UB-421 Phase III HAART Substitution Studymore
